Nobivac Canine Flu H3N8

MERCK

CANINE INFLUENZA VACCINE H3N8, Killed Virus FOR ANIMAL USE ONLY Nobivac® Canine Flu H3N8 is recommended for the vaccination of healthy dogs at 6 weeks of age or older as an aid in the control of disease associated with canine influenza virus infection. The type A, subtype H3N8 virus has been chemically inactivated and combined with an adjuvant designed to enhance the immune response. The vaccine has been demonstrated to reduce the incidence and severity of lung lesions, as well as the duration of coughing and viral shedding.

DOSAGE/ADMINISTRATION: Restricted to use by or under the direction of a veterinarian. Shake well. Inject one dose (1 mL) subcutaneously. The initial dose may be given at 6 weeks of age or older. A second dose is given 2 to 4 weeks later. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships. Use entire contents immediately.

See replacement product – Nobivac NXT Canine Flu H3N2 Vaccine, RNA Particle ( VANGUARD CIV H3N ) - ( VANGUARD CIV H3N2/H3N8 ) Call toll free 1-800-892-6978 or email us at info@animalhealthusa.com

A1-AD